Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 107

1.

Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial.

Goyal V, Grimwood K, Byrnes CA, Morris PS, Masters IB, Ware RS, McCallum GB, Binks MJ, Marchant JM, van Asperen P, O'Grady KF, Champion A, Buntain HM, Petsky H, Torzillo PJ, Chang AB.

Lancet. 2018 Oct 6;392(10154):1197-1206. doi: 10.1016/S0140-6736(18)31723-9. Epub 2018 Sep 18.

PMID:
30241722
2.

Antibiotics for prolonged wet cough in children.

Marchant JM, Petsky HL, Morris PS, Chang AB.

Cochrane Database Syst Rev. 2018 Jul 31;7:CD004822. doi: 10.1002/14651858.CD004822.pub3. Review.

PMID:
30062732
3.

Bacteria and viruses in the nasopharynx immediately prior to onset of acute lower respiratory infections in Indigenous Australian children.

Smith-Vaughan HC, Binks MJ, Beissbarth J, Chang AB, McCallum GB, Mackay IM, Morris PS, Marsh RL, Torzillo PJ, Wurzel DF, Grimwood K, Nosworthy E, Gaydon JE, Leach AJ, MacHunter B, Chatfield MD, Sloots TP, Cheng AC.

Eur J Clin Microbiol Infect Dis. 2018 Sep;37(9):1785-1794. doi: 10.1007/s10096-018-3314-7. Epub 2018 Jun 29.

PMID:
29959609
4.

Ear, nose and throat surgery: All you need to know about the surgical approach to the management of middle-ear effusions in Australian Indigenous and non-Indigenous children.

Kong K, Lannigan FJ, Morris PS, Leach AJ, O'Leary SJ.

J Paediatr Child Health. 2017 Nov;53(11):1060-1064. doi: 10.1111/jpc.13757. Review.

PMID:
29148198
5.

Culture-specific programs for children and adults from minority groups who have asthma.

McCallum GB, Morris PS, Brown N, Chang AB.

Cochrane Database Syst Rev. 2017 Aug 22;8:CD006580. doi: 10.1002/14651858.CD006580.pub5. Review.

PMID:
28828760
6.

Antibiotics for persistent cough or wheeze following acute bronchiolitis in children.

McCallum GB, Plumb EJ, Morris PS, Chang AB.

Cochrane Database Syst Rev. 2017 Aug 22;8:CD009834. doi: 10.1002/14651858.CD009834.pub3. Review.

PMID:
28828759
7.

Geographic consistency in dominant, non-typeable Haemophilus influenzae genotypes colonising four distinct Australian paediatric groups: a cohort study.

Smith-Vaughan HC, Beissbarth J, Bowman J, Hare KM, Price EP, Pickering J, Lehmann D, Chang AB, Morris PS, Marsh RL, Leach AJ.

Pneumonia (Nathan). 2016 Aug 18;8:13. doi: 10.1186/s41479-016-0013-y. eCollection 2016.

8.

Panel 1: Epidemiology and Diagnosis.

Homøe P, Kværner K, Casey JR, Damoiseaux RA, van Dongen TM, Gunasekera H, Jensen RG, Kvestad E, Morris PS, Weinreich HM.

Otolaryngol Head Neck Surg. 2017 Apr;156(4_suppl):S1-S21. doi: 10.1177/0194599816643510. Review.

PMID:
28372531
9.

Participatory systems approach to health improvement in Australian Aboriginal children.

McDonald EL, Bailie RS, Morris PS.

Health Promot Int. 2017 Feb 1;32(1):62-72. doi: 10.1093/heapro/dau003.

PMID:
28180314
10.

General health, otitis media, nasopharyngeal carriage and middle ear microbiology in Northern Territory Aboriginal children vaccinated during consecutive periods of 10-valent or 13-valent pneumococcal conjugate vaccines.

Leach AJ, Wigger C, Beissbarth J, Woltring D, Andrews R, Chatfield MD, Smith-Vaughan H, Morris PS.

Int J Pediatr Otorhinolaryngol. 2016 Jul;86:224-32. doi: 10.1016/j.ijporl.2016.05.011. Epub 2016 May 11.

11.

The short-term impact of each primary dose of pneumococcal conjugate vaccine on nasopharyngeal carriage: Systematic review and meta-analyses of randomised controlled trials.

Nicholls TR, Leach AJ, Morris PS.

Vaccine. 2016 Feb 3;34(6):703-13. doi: 10.1016/j.vaccine.2015.12.048. Epub 2015 Dec 29. Review.

12.

Risk factors for adverse outcomes of Indigenous infants hospitalized with bronchiolitis.

McCallum GB, Chatfield MD, Morris PS, Chang AB.

Pediatr Pulmonol. 2016 Jun;51(6):613-23. doi: 10.1002/ppul.23342. Epub 2015 Nov 17.

PMID:
26575201
13.

PneuMum: Impact from a randomised controlled trial of maternal 23-valent pneumococcal polysaccharide vaccination on middle ear disease amongst Indigenous infants, Northern Territory, Australia.

Binks MJ, Moberley SA, Balloch A, Leach AJ, Nelson S, Hare KM, Wilson C, Morris PS, Nelson J, Chatfield MD, Tang ML, Torzillo P, Carapetis JR, Mulholland EK, Andrews RM.

Vaccine. 2015 Nov 27;33(48):6579-87. doi: 10.1016/j.vaccine.2015.10.101. Epub 2015 Oct 31.

14.

Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.

Leach AJ, Wigger C, Hare K, Hampton V, Beissbarth J, Andrews R, Chatfield M, Smith-Vaughan H, Morris PS.

BMC Pediatr. 2015 Oct 19;15:162. doi: 10.1186/s12887-015-0483-8.

15.

Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo.

Hare KM, Grimwood K, Chang AB, Chatfield MD, Valery PC, Leach AJ, Smith-Vaughan HC, Morris PS, Byrnes CA, Torzillo PJ, Cheng AC.

Eur J Clin Microbiol Infect Dis. 2015 Nov;34(11):2275-85. doi: 10.1007/s10096-015-2480-0. Epub 2015 Sep 12.

PMID:
26363637
16.

The microbiome of otitis media with effusion in Indigenous Australian children.

Jervis-Bardy J, Rogers GB, Morris PS, Smith-Vaughan HC, Nosworthy E, Leong LE, Smith RJ, Weyrich LS, De Haan J, Carney AS, Leach AJ, O'Leary S, Marsh RL.

Int J Pediatr Otorhinolaryngol. 2015 Sep;79(9):1548-55. doi: 10.1016/j.ijporl.2015.07.013. Epub 2015 Jul 17.

PMID:
26228497
17.

Deriving accurate microbiota profiles from human samples with low bacterial content through post-sequencing processing of Illumina MiSeq data.

Jervis-Bardy J, Leong LE, Marri S, Smith RJ, Choo JM, Smith-Vaughan HC, Nosworthy E, Morris PS, O'Leary S, Rogers GB, Marsh RL.

Microbiome. 2015 May 5;3:19. doi: 10.1186/s40168-015-0083-8. eCollection 2015.

18.

Three-weekly doses of azithromycin for indigenous infants hospitalized with bronchiolitis: a multicentre, randomized, placebo-controlled trial.

McCallum GB, Morris PS, Grimwood K, Maclennan C, White AV, Chatfield MD, Sloots TP, Mackay IM, Smith-Vaughan H, McKay CC, Versteegh LA, Jacobsen N, Mobberley C, Byrnes CA, Chang AB.

Front Pediatr. 2015 Apr 21;3:32. doi: 10.3389/fped.2015.00032. eCollection 2015.

19.

Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial.

Leach AJ, Mulholland EK, Santosham M, Torzillo PJ, Brown NJ, McIntyre P, Smith-Vaughan H, Skull S, Balloch A, Andrews R, Carapetis J, McDonnell J, Krause V, Morris PS.

BMJ Open. 2015 Jan 16;5(1):e007247. doi: 10.1136/bmjopen-2014-007247.

20.

Indigenous child health: are we making progress?

Brewster DR, Morris PS.

J Paediatr Child Health. 2015 Jan;51(1):40-7. doi: 10.1111/jpc.12807. Epub 2014 Dec 23.

PMID:
25534334

Supplemental Content

Loading ...
Support Center